Article
A routine blood test could help to predict a patient’s likelihood to survive an aggressive form of skin cancer, researchers say.
Daily Derm Times: February 13, 2025
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
The Dermatology Industry Landscape: Unpacking Mergers and Acquisitions and Other Economic Movements
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Study Examines Connection Between Formulation and Benzene Levels in BPO Products
Balancing Biologics and Corticosteroids: Tailored Approaches for Managing Atopic Dermatitis